Beeton, Komal
Mitra, Dipanwita
Akinleye, Adesanya A.
Howell, John A.
Yu, Christian S.
Bidwell, Gene L. III
Tandon, Ritesh
Funding for this research was provided by:
National Institutes of Health
Article History
Received: 31 August 2023
Accepted: 26 April 2024
First Online: 4 May 2024
Competing interests
: G.L.B. is the owner of Leflore Technologies and is inventor on patents related to ELP drug delivery technology. Leflore Technologies had no input on the design, conduct, data interpretation, or publication of this study.